<div class="textg" style="text-align: justify; font-weight: lighter; line-height: 1.3em; font-size: 15px; border-radius: 3px; color: #80909a; padding: 10px; background-color: #F4F6F9; margin-bottom: 15px;">
 Neither the author, Tim Fries, nor this website, The Tokenist, provide financial advice. Please consult our&nbsp;<a href="https://tokenist.com/terms-of-service/" style="text-decoration:underline;color:#3c7b7b" target="_blank" rel="noopener noreferrer nofollow" class="deco-link">website policy</a>&nbsp;prior to making financial decisions.
</div>
<p class="has-drop-cap">Boston Scientific Corporation (BSX) has demonstrated a robust performance in the <a href="https://investors.bostonscientific.com" target="_blank" aria-label="third quarter of 2023 (opens in a new tab)" rel="noopener noreferrer nofollow" class="deco-link">third quarter of 2023</a>, underpinned by significant growth across its various segments. The company reported net sales of $3.527 billion, marking an 11.2% increase compared to the same period last year. This growth is even more pronounced on an operational and organic basis, with figures of 11.1% and 10.2%, respectively.</p>
<h3 id="bsx-reports-0-50-eps-and-3-73b-in-revenue-for-fiscal-q3">BSX Reports $0.50 EPS and $3.73B in Revenue for Fiscal Q3</h3>
<p>Earnings per share (EPS) also showed a positive trend, with a reported EPS of $0.34, significantly higher than the $0.12 in Q3 2022. <a href="https://tokenist.com/investing/fundamental-analysis-stocks/" rel="noopener noreferrer nofollow" class="deco-link">Adjusted EPS</a> was $0.50, compared to $0.43 in the prior year, reflecting the company’s effective management and strategic initiatives.</p>
<p>Boston Scientific’s performance this quarter has exceeded the market expectations set for them. Analysts had anticipated an EPS of $0.51 and revenue of $3.6 billion. However, the company reported an adjusted EPS of $0.50 and revenue of $3.73 billion. While slightly below the expected EPS, the company’s revenue aligns closely with forecasts.</p>
<div class="cta-referral"><img src="https://tokenist.com/wp-content/themes/thetokenist/assets/img/del/cta-referral-1.png" alt="" class="cta-referral__img" loading="lazy" decoding="async">
 <div class="cta-referral__text">
  <p>Join our&nbsp;<a href="https://t.me/thetokenist" target="_blank" rel="noopener noreferrer nofollow" class="deco-link">Telegram group&nbsp;and never miss a breaking digital asset story.</a></p>
 </div>
</div>
<h3 id="guidance">Guidance</h3>
<p>Boston Scientific has issued optimistic guidance for the fourth quarter of 2023, setting high expectations for continued growth. The company forecasts reported net sales growth between 9% and 11% and an adjusted EPS range of $0.49 to $0.52. <br><br>These projections indicate confidence in sustained momentum and operational efficiency. For the full year of 2023, the guidance includes an expected reported net sales growth of around 11% and an adjusted EPS of $1.99 to $2.02. This forward-looking outlook underscores the company’s strategic initiatives and its commitment to delivering value to its stakeholders.</p> <iframe src="https://tokenist.substack.com/embed" width="100%" height="320" style="border:1px solid #EEE; background:white;" frameborder="0" scrolling="no"></iframe>
<p><em>Disclaimer: The author does not hold or have a position in any securities discussed in the article.</em></p>
<h3 id="br"><br></h3>
<p>The post <a rel="noopener noreferrer nofollow" href="https://tokenist.com/boston-scientific-corporation-bsx-reports-0-50-adjusted-eps-3-73b-revenue-for-q3/">Boston Scientific Corporation (BSX) Reports $0.50 Adjusted EPS, $3.73B Revenue for Q3</a> appeared first on <a rel="noopener noreferrer nofollow" href="https://tokenist.com">Tokenist</a>.</p>

Boston Scientific Corporation (BSX) Reports $0.50 Adjusted EPS, $3.73B Revenue for Q3

Table of Contents

Tokenist

Other articles published on Jan 31, 2024

$FORWARD Token Continues Its Historic Sales Run with Epic Launch on Launchblocks!

Standard Chartered Eyes May Ether ETF Approval Date, $4,000 Price Prediction

Microsoft revenue up 18% after ‘infusing AI’ across tech stack

Top Trending Crypto Coins on DEXTools – Gemach, Hemule, TrustSwap Token

Meta, Snap Shares Dip After Google’s Ad Revenue Disappoints

Shiba Inu (SHIB) Anticipates Price Surge as Shibarium Network Targets Expansion

Join our free newsletter for daily crypto updates!